Camden National Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-80,191
| Closed | -$7.41M | – | 172 |
|
|
2024
Q2 | $7.41M | Buy |
80,191
+9,845
| +14% | +$909K | 1.14% | 45 |
|
|
2024
Q1 | $6.72M | Sell |
70,346
-519
| -0.7% | -$49.6K | 1.19% | 42 |
|
|
2023
Q4 | $5.4M | Sell |
70,865
-2,420
| -3% | -$185K | 1.01% | 48 |
|
|
2023
Q3 | $5.08M | Buy |
73,285
+149
| +0.2% | +$10.3K | 1.04% | 47 |
|
|
2023
Q2 | $6.9M | Sell |
73,136
-653
| -0.9% | -$61.6K | 1.35% | 33 |
|
|
2023
Q1 | $6.1M | Buy |
73,789
+678
| +0.9% | +$56.1K | 1.24% | 38 |
|
|
2022
Q4 | $5.46M | Sell |
73,111
-2,289
| -3% | -$171K | 1.14% | 43 |
|
|
2022
Q3 | $6.23M | Buy |
75,400
+277
| +0.4% | +$22.9K | 1.39% | 32 |
|
|
2022
Q2 | $7.14M | Buy |
75,123
+688
| +0.9% | +$65.4K | 1.48% | 25 |
|
|
2022
Q1 | $8.76M | Sell |
74,435
-163
| -0.2% | -$19.2K | 1.59% | 22 |
|
|
2021
Q4 | $9.66M | Sell |
74,598
-1,068
| -1% | -$138K | 1.7% | 17 |
|
|
2021
Q3 | $8.57M | Sell |
75,666
-751
| -1% | -$85K | 1.65% | 21 |
|
|
2021
Q2 | $7.91M | Sell |
76,417
-1,556
| -2% | -$161K | 1.49% | 25 |
|
|
2021
Q1 | $6.52M | Buy |
77,973
+709
| +0.9% | +$59.3K | 1.3% | 37 |
|
|
2020
Q4 | $7.05M | Sell |
77,264
-2,130
| -3% | -$194K | 1.47% | 28 |
|
|
2020
Q3 | $6.34M | Buy |
79,394
+48,274
| +155% | +$3.85M | 1.4% | 29 |
|
|
2020
Q2 | $2.15M | Buy |
+31,120
| New | +$2.15M | 0.53% | 52 |
|